部位 | ICD-O-3 | 合計 | 男性 | 女性 | |||
---|---|---|---|---|---|---|---|
件数 | % | 件数 | % | 件数 | % | ||
全部位 | 3,037 | 100.0% | 1,682 | 100.0% | 1,355 | 100.0% | |
食道 | C15 | 211 | 6.9% | 177 | 10.5% | 34 | 2.5% |
胃 | C16 | 233 | 7.7% | 176 | 10.5% | 57 | 4.2% |
大腸 | C18-C21 | 194 | 6.4% | 109 | 6.5% | 85 | 6.3% |
肝及び肝内胆管 | C22 | 107 | 3.5% | 70 | 4.2% | 37 | 2.7% |
膵 | C25 | 101 | 3.3% | 62 | 3.7% | 39 | 2.9% |
気管、気管支及び肺 | C33-C34 | 262 | 8.6% | 194 | 11.5% | 68 | 5.0% |
乳房 | C50 | 293 | 9.6% | 0 | 0.0% | 293 | 21.6% |
子宮 | C53-C54 | 190 | 6.3% | - | - | 190 | 14.0% |
前立腺 | C61 | 266 | 8.8% | 266 | 15.8% | - | - |
その他(100件未満)※4 | 1,180 | 38.9% | 628 | 37.3% | 552 | 40.7% |
※4 登録症例が年間100例に満たないものはその他に含みます。
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 合計 | |
---|---|---|---|---|---|
手術または内視鏡的治療合計割合 | 99.2% | 100.0% | 91.7% | 27.8% | 91.2% |
手術 | 37.1% | 100.0% | 91.7% | 27.8% | 42.9% |
(うち、体腔鏡的治療) | 22.7% | 12.5% | 0.0% | 0.0% | 18.2% |
内視鏡的治療 | 62.9% | 0.0% | 0.0% | 0.0% | 48.8% |
放射線療法 | 0.8% | 0.0% | 0.0% | 5.6% | 1.2% |
化学療法 | 3.0% | 25.0% | 66.7% | 77.8% | 16.5% |
レーザー等治療 | 6.8% | 0.0% | 0.0% | 0.0% | 5.3% |
その他 | 0.8% | 0.0% | 8.3% | 5.6% | 1.8% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療合計割合 | 100.0% | 87.0% | 100.0% | 100.0% | 61.1% | 100.0% | 87.3% |
手術 | 25.0% | 87.0% | 100.0% | 100.0% | 61.1% | 80.0% | 82.3% |
(うち、体腔鏡的治療) | 0.0% | 26.1% | 18.2% | 0.0% | 0.0% | 20.0% | 11.4% |
内視鏡的治療 | 75.0% | 0.0% | 0.0% | 0.0% | 0.0% | 20.0% | 5.1% |
放射線療法 | 0.0% | 8.7% | 0.0% | 5.6% | 5.6% | 20.0% | 6.3% |
化学療法 | 0.0% | 8.7% | 27.3% | 44.4% | 83.3% | 0.0% | 35.4% |
レーザー等治療 | 25.0% | 0.0% | 0.0% | 0.0% | 5.6% | 0.0% | 2.5% |
その他 | 0.0% | 8.7% | 0.0% | 0.0% | 5.6% | 0.0% | 3.8% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 合計 | |
---|---|---|---|---|---|
手術または内視鏡的治療合計割合 | 41.9% | 43.8% | 47.1% | 40.0% | 43.5% |
手術 | 41.9% | 43.8% | 47.1% | 40.0% | 43.5% |
放射線療法 | 6.5% | 0.0% | 5.9% | 20.0% | 5.8% |
化学療法 | 6.5% | 12.5% | 29.4% | 40.0% | 15.9% |
TAE | 35.5% | 43.8% | 17.6% | 20.0% | 31.9% |
レーザー等治療 | 35.5% | 18.8% | 0.0% | 0.0% | 20.3% |
その他 | 12.9% | 12.5% | 5.9% | 0.0% | 10.1% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 合計 | |
---|---|---|---|---|---|
手術または内視鏡的治療合計割合 | 79.8% | 61.5% | 26.1% | 11.7% | 47.9% |
手術 | 79.8% | 61.5% | 26.1% | 11.7% | 47.9% |
(うち、体腔鏡的治療) | 54.3% | 30.8% | 8.7% | 1.7% | 28.2% |
放射線療法 | 21.3% | 46.2% | 54.3% | 28.3% | 31.9% |
化学療法 | 13.8% | 7.7% | 84.8% | 81.7% | 47.9% |
免疫療法 | 0.0% | 0.0% | 0.0% | 0.5% | 0.5% |
その他 | 1.1% | 7.7% | 2.2% | 10.0% | 4.2% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 合計 | |
---|---|---|---|---|---|---|
手術の割合 | 100.0% | 93.3% | 93.5% | 100.0% | 16.7% | 90.4% |
放射線療法 | 46.2% | 42.2% | 35.5% | 66.7% | 0.0% | 40.4% |
化学療法 | 0.0% | 22.2% | 64.5% | 100.0% | 66.7% | 41.3% |
内分泌療法 | 76.9% | 62.2% | 29.0% | 33.3% | 50.0% | 51.0% |
免疫療法 | 0.0% | 0.0% | 0.0% | 0.0% | 16.7% | 1.0% |
その他 | 0.0% | 0.0% | 3.2% | 0.0% | 16.7% | 1.9% |
(重複あり)